AndhraNews.net
Home » BWI News » 2010 » October 2010 » October 27, 2010

Dr. A. S. Arvind Appointed Strategic Advisor at Ecron Acunova


October 27, 2010 - Bangalore, Karnataka, India

D. A Prasanna, Chairman of EA, announced the appointment of Dr. A S Arvind as Strategic Advisor.

Dr. Arvind will guide the company on operational excellence and will mentor the team. From his immense experience, Arvind will support the clients medically, scientifically and strategically in their clinical development plan.

Prior to EA, Dr. Arvind was Chief Operating Officer of Clinigene, CRO and a Biocon subsidiary. Joining Biocon in 2000 he played an integral role in development of Biocon’s pipeline and contributed to its strategic alliances with global majors.

Prior to Biocon, Dr. Arvind was Consultant Physician with West Wales General Hospital, and has held prestigious positions at UK hospitals. He worked as Medical Director and Consultant Gastroenterologist at Mallya Hospital, Bangalore

Dr. Arvind obtained MBA from the University of Birmingham, FRCP from the Royal Colleges of Physicians, London & Glasgow and MD from Bangalore Medical College.

D. A. Prasanna said, “Dr. Arvind brings in a wealth of experience in drug development and in areas of diabetes & biosimilars. His success in getting marketing authorization for Biocon, successful USFDA audit of sites and relationship with investigators will make a difference to our customers“

Dr. Arvind said, “I am excited to be part of Ecron Acunova that has grown manifold in a short time and has setup centers of excellence. I believe in this company’s strategy and look forward to contributing to its future”

Notes to the editor:Ecron Acunova is an expert CRO with 24 years of track record, providing services for Phase I-IV clinical research, including clinical trial management, CDM, PK/PD and central lab services with its research centers in Europe and India. EA operates each region as a priority market with European HQ at Frankfurt and Asian HQ at Bangalore. EA covers 15 European countries including Russia & Ukraine supplemented by alliance partners. With deep competence in conventional areas like oncology, EA provides unique expertise in imaging and stem cell trials. EA is committed to deliver speed-to-market cost effectively with no compromise on quality

To view the picture, please click on the link below:

Dr. Arvind

>

Dr Klaus D. Wiedey, Ecron Acunova, +49 69 66 80 30-0
DA Prasanna, Ecron Acunova, +91 80 66 91 57 01

Source: Business Wire India

BusinessWireIndia

Comment on this story

Share